Ansun Biopharma's Seed VC - II Round

Ansun Biopharma raised a round of funding on May 29, 2013. Investors include OrbiMed Advisors.

Ansun Biopharma is a clinical stage biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses.…

Articles about Ansun Biopharma's Seed VC - II Round: